Tags

Type your tag names separated by a space and hit enter

Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients.
Clin Breast Cancer. 2020 May 26 [Online ahead of print]CB

Authors+Show Affiliations

Department of Obstetrics and Gynecology, University Hospital MacDonald Women's Hospital, University Hospital Cleveland Medical Center, Cleveland, OH.Department of Medicine, University Hospitals Seidman Cancer Center, Cleveland, OH.Department of Obstetrics and Gynecology, University Hospital MacDonald Women's Hospital, University Hospital Cleveland Medical Center, Cleveland, OH. Electronic address: james.liu@uhhospitals.org.

Pub Type(s)

Case Reports

Language

eng

PubMed ID

32616435

Citation

Coyne, Kathryn, et al. "Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients." Clinical Breast Cancer, 2020.
Coyne K, Silverman P, Liu JH. Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients. Clin Breast Cancer. 2020.
Coyne, K., Silverman, P., & Liu, J. H. (2020). Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2020.05.011
Coyne K, Silverman P, Liu JH. Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients. Clin Breast Cancer. 2020 May 26; PubMed PMID: 32616435.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients. AU - Coyne,Kathryn, AU - Silverman,Paula, AU - Liu,James H, Y1 - 2020/05/26/ PY - 2020/02/28/received PY - 2020/05/01/revised PY - 2020/05/18/accepted PY - 2020/7/4/entrez KW - Elagolix KW - GnRH agonist KW - GnRH antagonist KW - Ovarian suppression KW - Premenopausal JF - Clinical breast cancer JO - Clin. Breast Cancer SN - 1938-0666 UR - https://www.unboundmedicine.com/medline/citation/32616435/Oral_GnRH_Antagonist_Ovarian_Suppression_After_Escape_From_GnRH_Agonist_in_Breast_Cancer_Patients L2 - https://linkinghub.elsevier.com/retrieve/pii/S1526-8209(20)30113-0 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.